Published in Cerebrovasc Dis on January 23, 2008
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development. Stroke (2008) 1.25
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke (2012) 1.10
Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models. J Transl Med (2010) 0.98
Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav (2012) 0.93
Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets. Transl Stroke Res (2014) 0.90
Neonatal giant pial arteriovenous malformation: genesis or rapid enlargement in the third trimester. J Neurointerv Surg (2009) 0.89
Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther (2011) 0.84
Cerebral aneurysms: formation, progression, and developmental chronology. Transl Stroke Res (2013) 0.83
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Clinical translation of angiogenesis inhibitors. Nat Rev Cancer (2002) 6.58
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A (1999) 3.96
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology (2006) 3.01
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke (2002) 2.30
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain (2002) 2.00
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol (2003) 1.93
Safety of doxycycline and minocycline: a systematic review. Clin Ther (2005) 1.89
Inflammation and intracranial aneurysms. Neurosurgery (1999) 1.74
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery (2001) 1.69
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg (2000) 1.50
Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf (2000) 1.44
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci (2006) 1.24
Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum (1999) 1.23
Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke (2002) 1.09
Evaluation of the hepatotoxic potential of minocycline. Antimicrob Agents Chemother (1991) 0.98
Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurol (2005) 0.98
Minocycline and lupuslike syndrome in acne patients. Arch Intern Med (1999) 0.96
Minocycline for Huntington's disease: an open label study. Neurology (2003) 0.89
The anti-inflammatory effects of tetracyclines. Cutis (2005) 0.85
Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases. Expert Opin Investig Drugs (2000) 0.83
Secondary prevention antibiotic treatment trials for coronary artery disease. Circulation (2000) 0.81
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol (2006) 8.02
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol (2004) 3.82
Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg (2006) 3.73
Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke (2007) 3.36
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol (2012) 3.23
MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell (2010) 3.18
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med (2005) 2.90
Ethics and sample size. Am J Epidemiol (2005) 2.88
Family history of diabetes as a potential public health tool. Am J Prev Med (2003) 2.76
A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med (2013) 2.70
Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke (2006) 2.68
Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60
NIH disease funding levels and burden of disease. PLoS One (2011) 2.56
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med (2008) 2.49
Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke (2004) 2.37
Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation (2005) 2.36
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol (2002) 2.34
Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke (2008) 2.32
Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening. Arch Womens Ment Health (2012) 2.26
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Idiopathic intracranial hypertension. Neurosurgery (2004) 2.21
Ultrasound visibility of needles used for regional nerve block: an in vitro study. Reg Anesth Pain Med (2004) 2.19
Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm (2003) 2.14
Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med (2012) 2.14
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07
Complications of lumboperitoneal shunts. Neurosurgery (2007) 2.07
Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery (2015) 2.05
Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care (2006) 2.05
Abortion and mental health: findings from The National Comorbidity Survey-Replication. Obstet Gynecol (2014) 2.02
Temporal lobe arteriovenous malformations: anatomical subtypes, surgical strategy, and outcomes. J Neurosurg (2013) 2.02
A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery (2010) 2.01
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery (2015) 1.99
Quantifying surgical access in eyebrow craniotomy with and without orbital bar removal: cadaver and surgical phantom studies. Acta Neurochir (Wien) (2013) 1.99
Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol (2010) 1.96
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J (2013) 1.91
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Weight, diet, and physical activity-related beliefs and practices among pregnant and postpartum Latino women: the role of social support. Matern Child Health J (2006) 1.84
Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol (2007) 1.83
Antibiotic treatment of acute respiratory infections in acute care settings. Acad Emerg Med (2006) 1.82
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med (2004) 1.79
Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science (2010) 1.79
Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke (2005) 1.78
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol (2005) 1.78
Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke (2004) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72
Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke (2008) 1.72
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69
Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis (2012) 1.68
Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery (2009) 1.68
Latent pattern mixture models for informative intermittent missing data in longitudinal studies. Biometrics (2004) 1.67
Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg (2006) 1.66
Predicting the effects of climate change on avian life-history traits. Proc Natl Acad Sci U S A (2002) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Comparative effectiveness of treatments for cerebral arteriovenous malformations: trends in nationwide outcomes from 2000 to 2009. Neurosurg Focus (2012) 1.66
Pediatric genitourinary injuries in the United States from 2002 to 2010. J Urol (2012) 1.65
Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med (2006) 1.61
Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke (2005) 1.61
Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol (2011) 1.55
"Tangential" resection of medial temporal lobe arteriovenous malformations with the orbitozygomatic approach. Neurosurgery (2004) 1.53
Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol (2010) 1.53